Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zibotentan + Pemetrexed in Previously Treated NSCLC
NCT00745875Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of zibotentan in non-small cell lung cancer (NSCLC), sponsored by AstraZeneca. Started Aug 2008; status: completed.
02
Drugs
zibotentan
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00745875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00745875.